Regular nutritional monitoring in pediatric cancer patients undergoing radiotherapy: a prospective observational pilot study
Frontiers in Oncology · 12.03.2026 · 16
DOI: 10.3389/fonc.2026.1752703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 12.03.2026. Verfasst von Dilek Gül und 5 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Clinic, Marmara University Pendik Education and Research Hospital, Istanbul, Türkiye. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
This pilot study aimed to explore the possible effects of regular, ongoing nutritional monitoring on dietary status, treatment results, and quality of life in pediatric cancer patients receiving radiotherapy. The study also sought to assess the potential role of caregiver nutritional support during treatment. Materials and methods Anthropometric measures, including weight, height, body mass index z-score (BMI), and mid-upper arm circumference (MUAC), were recorded for 15 patients. Individual nutritional plans, the quality of caregiver-provided nutritional support, and inflammatory parameters were assessed weekly during radiotherapy. Quality of life was measured using a validated questionnaire at the beginning and end of radiotherapy.
Results
More than one-third of patients were malnourished prior to radiotherapy. A decline was observed, especially in the fourth week of radiotherapy, for weight (p = 0.016), BMI (p = 0.013), and MUAC (p = 0.081). The albumin-to-globulin ratio (AGR) (p = 0.004) and platelet–lymphocyte ratio (PLR) (p = 0.013) peaked at the same time. Caregiver nutritional support scores (p = 0.026) and quality-of-life scores (p = 0.037) were lower in patients who experienced weight loss during radiotherapy. The median follow-up period was 13 months (range 9–16 months). Progression-free survival showed a non-significant trend in patients without weight loss [85.7% (95% CI, 42–99%) vs. 70% (95% CI, 35–93%), p = 0.590] and was significantly better in patients who began radiotherapy without malnutrition [100% (95% CI, 66–100%) vs. 50% (95% CI, 12–88%), p = 0.019].
Conclusion
Our initial findings suggest that regular nutritional monitoring may be a part of treatment plans, not just supportive care, for pediatric patients undergoing radiotherapy. Further research involving larger patient populations should be conducted to establish high-quality evidence on this topic.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiation Oncology Clinic, Marmara University Pendik Education and Research Hospital, Istanbul, Türkiye.
- Department of Nutrition and Dietetics, Marmara University Pendik Education and Research Hospital, Istanbul, Türkiye.
- Department of Pediatrics, Division of Oncology and Hematology, Marmara University School of Medicine, Istanbul, Türkiye.
- Department of Radiation Oncology, Marmara University School of Medicine, Istanbul, Türkiye.
- Department of Pediatrics, Division of Gastroenterology, Marmara University School of Medicine, Istanbul, Türkiye.
Zitieren
APA
Gül, D., Özdaş, F. E., Eker, N., Özgen, Z., Tutar, E., & Atasoy, B. M. (2026). Regular nutritional monitoring in pediatric cancer patients undergoing radiotherapy: a prospective observational pilot study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1752703
Vancouver
Gül D, Özdaş FE, Eker N, Özgen Z, Tutar E, Atasoy BM. Regular nutritional monitoring in pediatric cancer patients undergoing radiotherapy: a prospective observational pilot study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1752703
BibTeX
@article{Gl2026,
author = {Gül, Dilek and Özdaş, Feyzanur Ekşi and Eker, Nurşah and Özgen, Zerrin and Tutar, Engin and Atasoy, Beste Melek},
title = {Regular nutritional monitoring in pediatric cancer patients undergoing radiotherapy: a prospective observational pilot study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1752703}
}
EUVIMED